The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Screening alpha‐glucosidase and alpha‐amylase inhibitors from natural compounds by molecular docking in silico
Abstract
The alpha‐glucosidase inhibitor is a common oral anti‐diabetic drug used for controlling carbohydrates normally converted into simple sugars and absorbed by the intestines. However, some adverse clinical effects have been observed. The present study seeks an alternative drug that can regulate the hyperglycemia by down‐regulating alpha‐glucosidase and alpha‐amylase activity by molecular docking approach to screen the hyperglycemia antagonist against alpha‐glucosidase and alpha‐amylase activities from the 47 natural compounds. The docking data showed that Curcumin, 16‐hydroxy‐cleroda‐3,13‐dine‐16,15‐olide (16‐H), Docosanol, Tetracosanol, Antroquinonol, Berberine, Catechin, Quercetin, Actinodaphnine, and Rutin from 47 natural compounds had binding ability towards alpha‐amylase and alpha‐glucosidase as well. Curcumin had a better biding ability of alpha‐amylase than the other natural compounds. Analyzed alpha‐glucosidase activity reveals natural compound inhibitors (below 0.5 mM) are Curcumin, Actinodaphnine, 16‐H, Quercetin, Berberine, and Catechin when compared to the commercial drug Acarbose (3 mM). A natural compound with alpha‐amylase inhibitors (below 0.5 mM) includes Curcumin, Berberine, Docosanol, 16‐H, Actinodaphnine/Tetracosanol, Catechin, and Quercetin when compared to Acarbose (1 mM). When taken together, the implication is that molecular docking is a fast and effective way to screen alpha‐glucosidase and alpha‐amylase inhibitors as lead compounds of natural sources isolated from medicinal plants. © 2015 BioFactors, 41(4):242–251, 2015
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Comparative evaluation of 11 scoring functions for molecular docking.
Wang, R., Lu, Y., & Wang, S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0203783 · Cited by 849
Acarbose: oral antidiabetes drug with additional cardiovascular benefits
Hanefeld, M., & Schaper, F. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.2.153 · Cited by 87
Cited by
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., et al. (2019) · Theranostics · doi:10.7150/thno.30787 · Cited by 465
Rasouli, H., Hosseini-Ghazvini, S. M.-B., Adibi, H., & Khodarahmi, R. (2017) · Food & Function · doi:10.1039/c7fo00220c · Cited by 411
Xu, X.-Y., Meng, X., Li, S., Gan, R.-Y., Li, Y., & Li, H.-B. (2018) · Nutrients · doi:10.3390/nu10101553 · Cited by 358
Metadata
- Authors
- Jhong, C., Riyaphan, J., Lin, S., Chia, Y., & Weng, C.
- Venue
- BioFactors
- Publisher
- Wiley
- Published
- 2015-07-07
- Volume
- 41
- Issue
- 4
- Pages
- 242-251
- ISSN
- 0951-6433 (ISSN-L)
- 1872-8081
- OpenAlex
- W1946502985
- Cited by
- 171
- References
- 3
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening alpha‐glucosidase and alpha‐amylase inhibitors from natural compounds by molecular docking in silico. https://app.cochat.ai/papers/10.1002/biof.1219
- The paper
- Jhong, C., Riyaphan, J., Lin, S., Chia, Y., & Weng, C. (2015). Screening alpha‐glucosidase and alpha‐amylase inhibitors from natural compounds by molecular docking in silico. BioFactors. https://doi.org/10.1002/biof.1219
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.